Some thought about DVT prophylaxis in ICU.
Part of my presentation on the same topic.

Question 1: What is the incidence of DVT and PE in current era of widespread thrombo-prophylaxis?
#FOAMed

Question 2: How do you diagnose DVT in ICU?
▶️I think, the best evidence is available for CUS with limited scope for Venography.
And no role of D-Dimer.
#FOAMed
Question 3: Is there any evidence supporting Heparin thrombo-prophylaxis in ICU?
#FOAMed

Yes.
1⃣Number needed to prophylax to prevent 1 DVT - 20
2⃣Number needed to prophylax to prevent 1 PE - 52
3⃣Overall no major bleeding. But bleeding risk need to be individualised.
Question 4: Is there any evidence of LMWH over UFH in VTE Prophylaxis?
#FOAMeYes.
1⃣LMWH decreases DVT. But no difference in Proximal DVT.
2⃣No difference in PE.
3⃣No difference in major bleeding.
4⃣Lower incidence of HIT in LMWH (PROTECT Trial).
5⃣Overall advantage LMWH.
Question 5: Is there any role of Mechanical Thromboprophylaxis?
#FOAMed
Question 6: What is the evidence for Pharmacological Thromboprophylaxis in patients with low CrCL?

1⃣Maximum evidence is for Dabigatran.
2⃣But unfortunately even on Dabigtran with adequate Anti-factor Xa level maintained both DVT and bleeding risk remains high.
#FOAMed
Question 7: Any evidence in TBI?
#FOAMed
Suggestions.
1⃣GCS 13-15. No bleed expansion at 48-H. Start.
2⃣GCS 13-15. Some expansion at 48-H. Start only after 72-H.
3⃣GCS 3-12. Not before 72 H. But before 7-days.
4⃣For DAI. No bleeding. Start after 72-H.
5⃣Consult Neurosurgery.
Question 8: How to treat DVT in ICU?
#FOAMed
1⃣Standard anticoagulation.
2⃣Limited role for Catheter Directed Thrombolysis.
Question 9: How do I provide DVT prophylaxis in my ICU?
#FOAMed

1⃣All ICU patients need DVT prophylaxis.
2⃣Pharmacological preferred over Mechanical.
3⃣If DVT prophylaxis not given for some reason, the reason must be documented.
Question 10: Is there any evidence for DOACs?
#FOAMed
1⃣Yes. For several of them.
2⃣APEX supports Betrixaban for prophylaxis.
3⃣Xalia supports Rivaroxaban for treatment.
4⃣But will be cautious in using them in my patients. Limited evidence in ICU patients. Limited reversal agent.

More from Health

You May Also Like

https://t.co/6cRR2B3jBE
Viruses and other pathogens are often studied as stand-alone entities, despite that, in nature, they mostly live in multispecies associations called biofilms—both externally and within the host.

https://t.co/FBfXhUrH5d


Microorganisms in biofilms are enclosed by an extracellular matrix that confers protection and improves survival. Previous studies have shown that viruses can secondarily colonize preexisting biofilms, and viral biofilms have also been described.


...we raise the perspective that CoVs can persistently infect bats due to their association with biofilm structures. This phenomenon potentially provides an optimal environment for nonpathogenic & well-adapted viruses to interact with the host, as well as for viral recombination.


Biofilms can also enhance virion viability in extracellular environments, such as on fomites and in aquatic sediments, allowing viral persistence and dissemination.